Clinical trial
Deferoxamine for the Prevention of Cardiac Surgery-Associated Acute Kidney Injury
NCT04633889 is registered in ClinicalTrials.gov with Brigham and Women's Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Deferoxamine for the Prevention of Cardiac Surgery-Associated Acute Kidney Injury
- Lead sponsor
- Brigham and Women's Hospital
- Phase
- Phase 2
- Overall status
- Completed
- Start date
- April 13, 2021
- Completion date
- July 1, 2026
- Enrollment
- 320 (actual)
- Sites
- 3
Conditions
As the registry lists them; a condition with its own page is linked.